The role of meta-analysis in the regulatory process for foods, drugs, and devices

JAMA

Volumn 281, Issue 9, 1999, Pages 830-834

  Berlin, Jesse A ^a   Colditz, Graham A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG APPROVAL; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

EID: 0033518854     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.9.830     Document Type: Article

References (47)

1. Cook D, Sackett D, Spitzer W. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam consultation on meta-analysis. J Clin Epidemiol. 1995;48:167-171.
2. Oxman AD, Cook DJ, Guyatt GH, for the Evidence-Based Medicine Working Group. Users' guide to the medical literature, VI: how to use an overview. JAMA. 1994;272:1367-1371.
3. Lindsay M, Ehrenberg ASC. The design of replicated studies. Am Stat. 1993;47:217-228.
4. Whitehead A. A prospectively planned cumulative meta-analysis applied to a series of concurrent clinical trials. Stat Med. 1997;16:2901-2913.
5. Margitic SE, Morgan TM, Sager MA, Furberg CD. Lessons learned from a prospective meta-analysis. J Am Geriatr Soc. 1995;43:435-439.
6. Simes JR. Prospective meta-analysis of cholesterol-lowering studies: the Prospective Pravastatin Pooling (PPP) project and the Cholesterol Treatment Trialists (CTT) collaboration. Am J Cardiol. 1995;76:122c-126c.
7. Valsecchi MG, Masera G. A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup collaboration. Ann Oncol. 1996;7:1005-1008.
8. Shuster JJ, Gieser PW. Meta-analysis and prospective meta-analysis. Ann Oncol. 1996;7:1009-1014.
9. Steering Committee of the Physicians' Health Study. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;321:129-135.
10. Buring JE, Hennekens CH, and the Women's Health Study Research Group. The Women's Health Study: summary of the study design. Myocardial Ischemia. 1992;4:27-29.
11. O'Neill RT, Anello C. Does research synthesis have a place in drug regulatory policy? synopsis of issues: assessment of efficacy and drug approval. Clin Res Reg Aff. 1996;13:23-29.
12. Center for Drug Evaluation and Research. Guideline for the Format and Content of the Clinical and Statistical Sections of an Application. Rockville, Md: Food and Drug Administration, US Dept of Health and Human Services; 1988.
13. Temple R. The regulatory evolution of theintegrated safety summary Drug Inf J. 1992;25:485-492.
14. Dickman C, Yahiro M, Lu H, Melkerson M. Surgical treatment alternatives for fixation of unstable fractures of the thoracic and lumbar spine: a meta-analysis. Spine. 1994;19:22665-22735.
15. Food and Drug Administration (Docket No. 95P-0197). Food labeling: health claims; oats and coronary heart disease. Federal Register. 1997;62:3584-3601.
16. Food and Drug Administration (Docket No. 96P-0338). Food labeling: health claims; soluble fiber from certain foods and coronary heart disease. Federal Register. 1998;63:8103-8121.
17. Ripsin C, Keenan J, Jacobs D, et al. Oat products and lipid lowering: a meta-analysis. JAMA. 1992;267: 3317-3325.
18. Olson B, Anderson S, Becker M, et al. Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysis. J Nutr. 1997;127:1973-1980.
19. Probstfield J, Applegate WB. Prospective meta-analysis: ahoy! a clinical trial? J Am Geriatr Soc. 1995; 43:452-453.
20. Berkey CS, Hoaglin D, Mosteller F, Colditz GA. A random-effects regression model for meta-analysis. Stat Med. 1995;14:395-411.
21. Berlin J, Antman E. Advantages and limitations of metaanalytic regressions of clinical trials data. Online J Curr Clin Trials [serial online]. 1994:3(Doc No. 134).
22. Berkey C, Mosteller F, Lau J, Antman E. Uncertainty of the time of first significance in random effects cumulative meta-analysis. Control Clin Trials. 1996;17:357-371.
23. Begg CB. The role of meta-analysis in monitoring clinical trials. Stat Med. 1996;15:1299-1306.
24. Langhorne P. Bias in meta-analysis detected by a simple, graphical test: prospectively identified trials could be used for comparison with meta-analysis. BMJ. 1998;316:471.
25. Simes JR. Publication bias: the case for an international registry of clinical trials. J Clin Oncol. 1986; 4:1529-1541.
26. Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer. Cancer Causes Control. 1996;7:157-177.
27. Alpha-Tocopherol Beta-Carotene Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
28. Hennekens C, Buring J, Manson J, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.
29. Omenn G, Goodman G, Thornquist M, et al. Effect of combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150-1155.
30. Berlin J, Longnecker M, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology. 1993;4:218-228.
31. Tweedie RL, Mengersen KL. Meta-analytic approaches to dose-response relationships with application in studies of lung cancer and exposure to environmental tobacco smoke. Stat Med. 1995;14:545-569.
32. Smith SJ, Caudill P, Steinberg KK, Thacker SB. On combining dose-response data from epidemiologic studies by meta-analysis. Stat Med. 1995;14:531-544.
33. LeLorier J, Gregoire G, Benhaaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent larger randomized controlled trials N Engl J Med. 1997;337:536-542.
34. Ioannidis J, Cappelleri J, Lau J. Issues in comparison between meta-analyses and large trials. JAMA. 1998;279:1089-1093.
35. Cappelleri JC, Ioannidis JPA, Schmid CH, et al. Large trials vs meta-analysis of smaller trials: do their results compare? JAMA. 1996;276:1332-1338.
36. Mosteller F, Chalmers T. Some progress and problems in meta-analysis of clinical trials. Stat Sci. 1992; 7:227-236.
37. Yusuf S, Collins R, MacMahon S, Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction : overview of the randomised trials. Lancet. 1988;1:1088-1092.
38. Yusuf S, Flather M. Magnesium in acute myocardial infarction. BMJ. 1995;310:751-752.
39. ISIS-4 Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669-685.
40. Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomized trials. BMJ. 1991;303:1499-1503.
41. Colditz GA, Brewer TF, Berkey CS, et al. The efficacy of BCG vaccination in the prevention of tuberculosis: meta-analysis of the published literature. JAMA. 1994;271:698-702.
42. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995;96:29-35.
43. Egger M, Smith GD. Misleading meta-analysis: lessons from "an effective, safe, and simple" intervention that wasn't. BMJ. 1995;310:752-754.
44. Charlton BG. Practice guidelines and practical judgement: the role of mega-trials, meta-analysis and consensus. Br J Gen Pract. 1994;44:290-291.
45. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992;339:1553-1558.
46. Antman EM. Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story. Am J Cardiol. 1995;75:391-393.
47. Antman E, Seelig M, Fleischmann K, et al. Magnesium in acute myocardial infarction: scientific, statistical, and economic rationale for its use. Cardiovasc Drugs Ther. 1996;10:297-301.